The Impact of Screening Mammography
Creator:   Prof. Jaak Ph. Janssens
Created:   12/26/2011
Contains:  4 items
With breast cancer incidence doubling during the last 40 years and stabilization of mortality, cure rates have increased from 50 up to 80 percent. Two main hypothesis need consideration: the effect of early detection and improved treatments. While there is considerable debate about the impact of both, recent publications have fueled the discussion on the effects of screening mammography. An upcoming paper of Bulliard and Levi (due as a Publish Ahead-of Print article in February 2012) provides evidence that the impact of screening is decreasing because of therapeutic advances. And if the impact is lower, more attention should be given to the psychological harms and cost-benefit issues.

A pooled analysis of interval cancer rates in six European countries

Törnberg, Sven; Kemetli, Levent; Ascunce, Nieves; More

European Journal of Cancer Prevention . 19(2):87-93, March 2010.

Large variations in screening sensitivity and performance are seen in the European Community, indicating room for quality improvement.

Breast cancer screening in women aged 50–74 years: isthereroom for improvement?

Morère, Jean-François; Pivot, Xavier; Viguier, Jérôme; More

European Journal of Cancer Prevention . 20():S8-S12, January 2011.

The impact of mammography screening may be improved by systematic organized screening, by encouraging regular examination and by targeting women who give up screening.

Mammography utilization in women aged 40–49 years: the French EDIFICE survey

Pivot, Xavier; Eisinger, François; Blay, Jean-Yves; More

European Journal of Cancer Prevention . 20():S16-S19, January 2011.

EDIFICE, the iterative nationwide survey, collected data in France and made contributions to the debate on risk/benefit of breast cancer screening for women in their 40s.

Uptake of breast cancer screening in women aged over 75years: a controversy to come?

Eisinger, François; Viguier, Jérôme; Blay, Jean-Yves; More

European Journal of Cancer Prevention . 20():S13-S15, January 2011.

For women aged 75 and above, anestimated 17 000 000 Euros are spent each year on breast cancer screening in France, the net benefit of which is still unknown.